Unknown

Dataset Information

0

SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.


ABSTRACT: The SARS-CoV-2 variant of concern, α, spread worldwide at the beginning of 2021. It was suggested that this variant was associated with a higher risk of mortality than other variants. We aimed to characterize the genetic diversity of SARS-CoV-2 variants isolated from patients with severe COVID-19 and unravel the relationships between specific viral mutations/mutational patterns and clinical outcomes. This is a prospective multicenter observational cohort study. Patients aged ≥18 years admitted to 11 intensive care units (ICUs) in hospitals in the Greater Paris area for SARS-CoV-2 infection and acute respiratory failure between 1 October 2020 and 30 May 2021 were included. The primary clinical endpoint was day-28 mortality. Full-length SARS-CoV-2 genomes were sequenced by means of next-generation sequencing (Illumina COVIDSeq). In total, 413 patients were included, 183 (44.3%) were infected with pre-existing variants, 197 (47.7%) were infected with variant α, and 33 (8.0%) were infected with other variants. The patients infected with pre-existing variants were significantly older (64.9 ± 11.9 vs. 60.5 ± 11.8 years; p = 0.0005) and had more frequent COPD (11.5% vs. 4.1%; p = 0.009) and higher SOFA scores (4 [3-8] vs. 3 [2-4]; 0.0002). The day-28 mortality was no different between the patients infected with pre-existing, α, or other variants (31.1% vs. 26.2% vs. 30.3%; p = 0.550). There was no association between day-28 mortality and specific variants or the presence of specific mutations. At ICU admission, the patients infected with pre-existing variants had a different clinical presentation from those infected with variant α, but mortality did not differ between these groups. There was no association between specific variants or SARS-CoV-2 genome mutational pattern and day-28 mortality.

SUBMITTER: Fourati S 

PROVIDER: S-EPMC9322524 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.

Fourati Slim S   Audureau Etienne E   Arrestier Romain R   Marot Stéphane S   Dubois Claire C   Voiriot Guillaume G   Luyt Charles-Edouard CE   Urbina Tomas T   Mayaux Julien J   Roque-Afonso Anne-Marie AM   Pham Tài T   Landraud Luce L   Visseaux Benoit B   Roux Damien D   Bellaiche Raphael R   L'honneur Anne-Sophie AS   Ait Hamou Zakaria Z   Brichler Ségolène S   Gaudry Stéphane S   Salmona Maud M   Clere-Jehl Raphaël R   Azoulay Elie E   Morand-Joubert Laurence L   Marcelin Anne-Geneviève AG   Chaix Marie-Laure ML   Descamps Diane D   Mekontso Dessap Armand A   Rodriguez Christophe C   Pawlotsky Jean-Michel JM   de Prost Nicolas N  

Viruses 20220713 7


The SARS-CoV-2 variant of concern, α, spread worldwide at the beginning of 2021. It was suggested that this variant was associated with a higher risk of mortality than other variants. We aimed to characterize the genetic diversity of SARS-CoV-2 variants isolated from patients with severe COVID-19 and unravel the relationships between specific viral mutations/mutational patterns and clinical outcomes. This is a prospective multicenter observational cohort study. Patients aged ≥18 years admitted t  ...[more]

Similar Datasets

| S-EPMC9020190 | biostudies-literature
| S-EPMC7938739 | biostudies-literature
| S-EPMC7258645 | biostudies-literature
| S-EPMC11429030 | biostudies-literature
| S-EPMC9420902 | biostudies-literature
| S-EPMC5003603 | biostudies-literature
2021-12-08 | GSE180578 | GEO
| S-EPMC7306494 | biostudies-literature
| S-EPMC8801309 | biostudies-literature
| S-EPMC9767656 | biostudies-literature